3 Stocks With Recent Intensive Insider Buying

|
 |  Includes: NTIOF, PFSCF, STADF
by: Markus Aarnio

Since my November 28, 2012, article titled "5 Stocks With Recent Intensive Insider Buying", the stocks that I featured have performed as follows:

Company Price 11/27 Price 2/20 Change
ARR $6.87 $6.61 -3.8%
OILT $37.05 $44.00 +18.8%
FFCO $16.40 $16.33 -0.4%
OFG $11.85 $15.08 +27.3%
WFT $9.77 $12.93 +32.3%
Click to enlarge

In this article, I will feature three additional stocks that have seen intensive insider buying during the last 30 days. Intensive insider buying can be defined by the following three criteria:

  1. The stock is purchased by three or more insiders within one month.
  2. The stock is sold by no insiders in the month of intensive purchasing.
  3. At least two purchasers increase their holdings by more than 10%.

1. National Bank of Canada (OTCPK:NTIOF) provides various financial services to retail, commercial, corporate, and institutional clients primarily in Canada, the United States, and Europe.

Click to enlarge
(Click to enlarge)

Insider buying by insider (last 30 days)

  • Paul Gobeil purchased 122 shares on February 15 and currently holds 14,537 shares or less than 0.1% of the company. Paul Gobeil serves as a director of the company.
  • Gérard Coulombe purchased 137 shares on February 15 and currently holds 7,015 shares or less than 0.1% of the company. Gérard Coulombe serves as a director of the company.
  • André Caillé purchased 150 shares on February 15 and currently holds 4,499 shares or less than 0.1% of the company. André Caillé serves as a director of the company.
  • Pierre Thabet purchased 115 shares on February 15 and currently holds 685 shares or less than 0.1% of the company. Pierre Thabet serves as a director of the company.
  • Lino Saputo purchased 124 shares on February 15 and currently holds 1,395 shares or less than 0.1% of the company. Lino Saputo serves as a director of the company.
  • Roseann Runte purchased 110 shares on February 15 and currently holds 5,900 shares or less than 0.1% of the company. Roseann Runte serves as a director of the company.
  • Louise Laflamme purchased 129 shares on February 15 and currently holds 7,771 shares or less than 0.1% of the company. Louise Laflamme serves as a director of the company.
  • Jean Houde purchased 103 shares on February 15 and currently holds 5,969 shares or less than 0.1% of the company. Jean Houde serves as a director of the company.
  • Jean Douville purchased 113 shares on February 15 and currently holds 8,351 shares or less than 0.1% of the company. Jean Douville is Chairman of the Board.
  • Gillian Denham purchased 99 shares on February 15 and currently holds 5,663 shares or less than 0.1% of the company. Gillian Denham serves as a director of the company.
  • Bernard Cyr purchased 215 shares on February 15 and currently holds 7,851 shares or less than 0.1% of the company. Bernard Cyr serves as a director of the company.
  • Lawrence Bloomberg purchased 92 shares on February 15 and currently holds 1,401 shares or less than 0.1% of the company. Lawrence Bloomberg serves as a director of the company.
  • Maryse Bertrand purchased 103 shares on February 15 and currently holds 1,077 shares or less than 0.1% of the company. Maryse Bertrand serves as a director of the company.

Insider buying by calendar month

Here is a table of National Bank of Canada's insider trading activity by calendar month.

Month Insider buying / shares Insider selling / shares
February 2013 1,612 0
January 2013 0 0
December 2012 752 149,100
November 2012 1,746 0
October 2012 680,000 0
September 2012 160,000 10,983
Click to enlarge

There have been 844,110 shares purchased and 160,083 shares sold since September 2012.

Financials

The company reported the full fiscal year 2012, which ended October 31, 2012, financial results on December 6, 2012, with the following highlights:

Net income $1.6 billion
Book value $40.04 per share
Click to enlarge

Competition

National Bank of Canada's competitors include Bank of Montreal (NYSE:BMO), The Bank Of Nova Scotia (NYSE:BNS) and Royal Bank of Canada (NYSE:RY). Here is a table comparing these companies.

Company NTIOF.PK BMO BNS RY
Market Cap: 12.60B 40.50B 68.88B 90.91B
Employees: 19,920 46,272 81,497 74,377
Qtrly Rev Growth (yoy): 0.17 0.15 0.08 0.09
Revenue: 5.26B 15.66B 18.80B 28.84B
Operating Margin: 0.40 0.36 0.44 0.36
Net Income: 1.55B 4.06B 6.14B 7.37B
EPS: 9.50 6.27 5.32 5.02
P/E: 8.24 9.93 10.93 12.53
PEG (5 yr expected): 0.99 1.58 1.36 1.33
P/S: 2.40 2.59 3.66 3.15
Click to enlarge
Click to enlarge

National Bank of Canada's P/S ratio and P/E ratio are below these competitors.

My analysis

The stock has a $110 price target from the Point and Figure chart. There have been 13 different insiders buying and there have not been any insiders selling the shares during the past 30 days. I have a cautiously bullish bias for the stock currently based on the low valuation compared to its competitors.

2. ProMetic Life Sciences (OTCQX:PFSCF), a biopharmaceutical company, engages in the research, development, manufacture, and marketing of drug therapeutics and protein technologies.

Click to enlarge
(Click to enlarge)

Insider buying by insider (last 30 days)

  • John Moran purchased 51,571 shares on February 5 and currently holds 51,571 shares or less than 0.1% of the company. John Moran serves as a director of the company.
  • Frédéric Dumais purchased 15,000 shares on February 5 and currently holds 340,000 shares or less than 0.1% of the company. Frédéric Dumais is senior officer of the company.
  • Patrick Sartore purchased 30,000 shares on February 5 and currently holds 30,000 shares or less than 0.1% of the company. Patrick Sartore joined ProMetic in 2006 as Senior Legal Counsel - Intellectual Property and has since been nominated as Corporate Secretary of the company.
  • Benjamin Wygodny purchased 539,383 shares on February 14 and currently controls 3,257,312 shares or 0.7% of the company. Benjamin Wygodny serves as a director of the company.

Insider buying by calendar month

Here is a table of ProMetic Life Sciences' insider trading activity by calendar month.

Month Insider buying / shares Insider selling / shares
February 2013 635,954 0
January 2013 15,000 0
December 2012 48,203,053 0
November 2012 0 0
October 2012 25,000 0
September 2012 25,000 0
Click to enlarge

There have been 48,904,007 shares purchased and zero shares sold since September 2012.

Financials

The company reported the third-quarter financial results on November 13 with the following highlights:

Revenue $7.7 million
Net income $2.5 million
Cash $0.6 million
Debt $5.4 million
Click to enlarge

On January 8, 2013, ProMetic announced that it had finalized the $10 million strategic equity investment in ProMetic by Shenzhen Hepalink Pharmaceutical pursuant to the terms and conditions previously disclosed on October 16, 2012.

News

On January 18, 2013, ProMetic announced that it has received confirmation from Octapharma of the regulatory approval of Octaplas by the Food and Drug Administration for the US market.

ProMetic's proprietary prion capture resin, PrioClear, is incorporated in Octapharma's manufacturing process for its solvent/detergent treated, prion-reduced, plasma product, Octaplas.

ProMetic received purchase orders from Octapharma exceeding $6 million for PrioClear resin in 2012 for approved European countries and to support product launch in new European territories.

My analysis

There have been four different insiders buying and there have not been any insiders selling the shares during the past 30 days. I have a cautiously bullish bias for the stock currently based on the intensive insider buying and the recent business developments.

3. St Andrew Goldfields (OTCQX:STADF) is a gold mining and exploration company with an extensive land package in the Timmins mining district, north-eastern Ontario, which lies within the Abitibi greenstone belt, the most important host of historical gold production in Canada.

SAS owns and operates the Holt, Holloway and Hislop mines with annual gold production of approximately 100,000 ounces. The company is also advancing the Taylor Project and is conducting aggressive exploration across 120km of land straddling the Porcupine-Destor Fault Zone.

Click to enlarge
(Click to enlarge)

Insider buying by insider (last 30 days)

  • Douglas Cater purchased 3,508 shares on February 12 pursuant to a purchase/ownership plan. Douglas Cater currently holds 3,508 shares or less than 0.1% of the company. Douglas Cater joined SAS in June 2012 as Vice President of Exploration.
  • Duncan Middlemiss purchased 4,824 shares on February 11 pursuant to a purchase/ownership plan. Duncan Middlemiss currently holds 110,283 shares or less than 0.1% of the company. Duncan Middlemiss is Vice President, General Manager - Operations, East Timmins.
  • Jacques Perron purchased 3,264 shares on February 11 pursuant to a purchase/ownership plan. Jacques Perron currently holds 286,848 shares or less than 0.1% of the company. Jacques Perron is President, Chief Executive Officer, Director.
  • Geoffrey Ramey purchased 2,894 shares on February 11 pursuant to a purchase/ownership plan. Geoffrey Ramey currently holds 49,665 shares or less than 0.1% of the company. Geoffrey Ramey is Vice President, Human Resources.
  • Pierre Rocque purchased 3,438 shares on February 11 pursuant to a purchase/ownership plan. Pierre Rocque currently holds 71,845 shares or less than 0.1% of the company. Pierre Rocque is Vice President of Engineering.
  • Linda Weinzettl purchased 1,774 shares on February 11 pursuant to a purchase/ownership plan. Linda Weinzettl currently holds 14,395 shares or less than 0.1% of the company. Linda Weinzettl is Corporate Secretary.

Insider buying by calendar month

Here is a table of St Andrew Goldfields' insider trading activity by calendar month.

Month Insider buying / shares Insider selling / shares
February 2013 19,702 0
January 2013 13,792 0
December 2012 17,912 0
November 2012 15,134 0
October 2012 14,203 0
September 2012 12,709 0
Click to enlarge

There have been 93,452 shares purchased and zero shares sold since September 2012.

Financials

The company reported the full year 2012 financial results on February 14 with the following highlights:

Revenue $156.4 million
Net income $26.0 million
Cash $30.7 million
Debt $18.6 million
Gold production 95,604 ounces
Click to enlarge

Outlook

SAS provided 2013 production guidance of between 95,000 - 105,000 ounces of gold, an increase over 2012 with similar cash cost guidance of between $800-$850 per ounce, before royalties.

My analysis

There have been six different insiders buying and there have not been any insiders selling the shares during the past 30 days. The Taylor project, which will be the company's fourth operating mine, is expected to commence production in 2014. The outlook for the 2014 gold production is 120,000 - 130,000 ounces. The stock is currently trading at a P/E ratio of 6.00. I believe the stock could be a good pick from the current level.

Disclosure: I am long ARR. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.